Physician profile
James Bleiler
NPI 1679539506
$12,149.58
in general payments reported to CMS, 2019-2025
61 companies · $1,948 in 2025
The $1,948 reported for 2025 was more than what 79% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,213 · 2020: $820 · 2021: $1,221 · 2022: $2,544 · 2023: $1,490 · 2024: $1,912 · 2025: $1,948.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,273 · Education: $77.97.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,272.92 |
| Education | $77.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $1,752.90 | 2021-2024 | Urolift |
| Neotract INC. | $1,464.02 | 2019-2020 | |
| Astellas Pharma US INC | $1,101.39 | 2019-2025 | Xtandi, Myrbetriq |
| Janssen Biotech, INC. | $946.88 | 2019-2025 | Erleada, Akeega, Balversa |
| Sumitomo Pharma America, INC. | $715.01 | 2023-2025 | Gemtesa, Orgovyx |
| Pfizer INC. | $631.83 | 2019-2025 | |
| 180 Medical, INC. | $340.68 | 2019-2025 | Gentlecath, Gentlecath Glide, Magic3 Intermittent Catheter |
| Endo Pharmaceuticals INC. | $319.42 | 2019-2024 | Aveed, Xiaflex |
| Myriad Genetic Laboratories, INC. | $297.46 | 2021-2024 | Prolaris, Myrisk |
| Ferring Pharmaceuticals INC. | $294.36 | 2024-2025 | Adstiladrin |
| Merck Sharp & Dohme LLC | $283.69 | 2020-2025 | Keytruda, Lynparza, Welireg |
| Boston Scientific Corporation | $280.16 | 2019-2021 | |
| Coloplast Corp | $248.85 | 2019-2025 | |
| Endo USA, INC. | $229.45 | 2024-2025 | Xiaflex, Aveed |
| Astrazeneca Pharmaceuticals LP | $226.49 | 2023-2025 | Lynparza |
Show all 61 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $219.96 | 2023-2025 | |
| Dendreon Pharmaceuticals LLC | $189.04 | 2020-2023 | Provenge |
| Urogen Pharma, INC. | $186.01 | 2020-2025 | Jelmyto |
| Procept Biorobotics Corporation | $151.15 | 2025 | |
| Histosonics, INC. | $148.88 | 2025 | |
| Progenics Pharmaceuticals, INC. | $145.99 | 2021-2025 | |
| Abbvie INC. | $142.23 | 2022-2025 | Botox |
| Urovant Sciences INC | $135.48 | 2021-2022 | |
| Sun Pharmaceutical Industries INC. | $104.15 | 2024-2025 | |
| Antares Pharma, INC. | $92.60 | 2024-2025 | Xyosted |
| Convatec INC. | $86.96 | 2023-2024 | |
| Myovant Sciences INC. | $86.02 | 2021-2022 | |
| Ethicon US, LLC | $81.04 | 2019-2024 | Vistaseal, Echelon Endopath |
| Tolmar Pharmaceuticals, INC. | $80.95 | 2020-2021 | |
| Agiliti Surgical, INC. | $80.49 | 2023 | Trinity, Sonablate, Soltive |
| Axonics, INC. | $69.15 | 2020-2021 | |
| Blue Earth Diagnostics | $64.11 | 2019-2021 | |
| Tolmar, INC. | $62.20 | 2023-2025 | Jatenzo, Eligard |
| Immunitybio, INC. | $57.10 | 2024-2025 | |
| C. R. Bard, INC. & Subsidiaries | $56.41 | 2024 | Bard Urinary Drainage Bag |
| Laborie Medical Technologies Corp. | $55.11 | 2020-2023 | |
| Rochester Medical Corporation | $52.97 | 2020-2022 | |
| Bioprotect Medical, INC. | $49.45 | 2024 | Bioprotect Balloon Implant System |
| Olympus America INC. | $48.62 | 2022-2025 | Itind System |
| Mission Pharmacal Company | $44.01 | 2022-2023 | Uribel |
| Alnylam Pharmaceuticals INC. | $42.27 | 2023-2024 | Givlaari |
| E.R. Squibb & Sons, L.L.C. | $38.76 | 2022-2023 | Opdivo |
| Allergan, INC. | $35.17 | 2021 | |
| Palette Life Sciences, INC. | $33.19 | 2022 | |
| Acerus Pharmaceuticals Corporation | $31.59 | 2022 | |
| Genzyme Corporation | $29.64 | 2022 | |
| Becton, Dickinson and Company | $26.54 | 2025 | Magic3 Go Intermittent Urinary Catheter |
| Cook Medical LLC | $25.42 | 2024 | Litho 150 |
| Calyxo, INC. | $25.09 | 2025 | Cvac Aspiration System |
| Accord Healthcare, INC. | $23.78 | 2025 | |
| Novartis Pharmaceuticals Corporation | $23.68 | 2024 | |
| Telix Pharmaceuticals | $23.54 | 2023 | Illuccix |
| Ethicon INC. | $23.23 | 2021 | |
| Novo Nordisk INC | $22.02 | 2024 | |
| Metuchen Pharmaceuticals | $20.37 | 2019 | |
| Ambu INC. | $19.53 | 2020-2021 | |
| Foundation Medicine, INC. | $17.40 | 2022 | |
| Abc Home Medical Supply, INC. | $16.62 | 2024 | |
| Hollister Incorporated | $16.62 | 2024 | |
| Isoray, INC | $16.46 | 2024 | Brachytherapy Source |
| Medtronic, INC. | $15.99 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Bleiler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.